Fathi Adel A, Soliman Mahmoud M
Ain Shams University, Cairo, Egypt.
J Cataract Refract Surg. 2002 Mar;28(3):513-6. doi: 10.1016/s0886-3350(01)01140-3.
To compare carticaine 4% and lidocaine 2% for peribulbar anesthesia in cataract surgery.
Ain Shams and Cairo University Hospitals, Cairo, Egypt.
This prospective double-blind randomized study comprised 200 cataract patients assigned to 1 of 2 groups of 100 each based on type of anesthesia: carticaine 4% or lidocaine 2%. The efficacy, safety, and duration of the motor and the analgesic block produced by carticaine 4% adrenaline hyaluronidase mixture and lidocaine 2% adrenaline hyaluronidase mixture used as peribulbar anesthesia were compared. The mean time for satisfactory block, need for supplementary injections, incidence of intraoperative and postoperative pain, and postoperative complications were evaluated. The data were analyzed using the Student t test and Mann-Whitney U test for intergroup differences. The chi-square or Fisher exact test was used to assess eye movement scores, the need for supplementary injections, the onset of postoperative pain, and the incidence of postoperative complications.
The mean time for satisfactory anesthesia was 7.5 minutes +/- 1.68 (SD) for lidocaine 2% and 2.5 +/- 1.53 minutes for carticaine 4% (P <.001). The need for supplementary injections was 28% in the lidocaine group and 4% in the carticaine group (P <.001). The mean onset of postoperative pain was 2.00 +/- 0.86 hours in the lidocaine group and 5.52 +/- 1.80 hours in the carticaine group (P <.05). There were no cases of postoperative neurotoxicity or extraocular muscle dysfunction in either group.
Carticaine 4% adrenaline hyaluronidase mixture was an effective and safe agent for peribulbar anesthesia. It was more efficient than lidocaine 2% adrenaline hyaluronidase mixture in the onset and quality of anesthesia as well as postoperative analgesia.
比较4%卡替卡因和2%利多卡因用于白内障手术球周麻醉的效果。
埃及开罗艾因夏姆斯大学医院和开罗大学医院。
这项前瞻性双盲随机研究纳入了200例白内障患者,根据麻醉类型分为两组,每组100例:4%卡替卡因组或2%利多卡因组。比较了4%卡替卡因肾上腺素透明质酸酶混合物和2%利多卡因肾上腺素透明质酸酶混合物用于球周麻醉时产生的运动阻滞和镇痛阻滞的效果、安全性及持续时间。评估了达到满意阻滞的平均时间、追加注射的需求、术中和术后疼痛的发生率以及术后并发症。采用Student t检验和Mann-Whitney U检验分析组间差异。使用卡方检验或Fisher精确检验评估眼球运动评分、追加注射的需求、术后疼痛的发作情况以及术后并发症的发生率。
2%利多卡因达到满意麻醉的平均时间为7.5分钟±1.68(标准差),4%卡替卡因组为2.5±1.53分钟(P<.001)。利多卡因组追加注射的需求为28%,卡替卡因组为4%(P<.001)。利多卡因组术后疼痛的平均发作时间为2.00±0.86小时,卡替卡因组为5.52±1.80小时(P<.05)。两组均未出现术后神经毒性或眼外肌功能障碍的病例。
4%卡替卡因肾上腺素透明质酸酶混合物是一种用于球周麻醉的有效且安全的药物。在麻醉起效、质量以及术后镇痛方面,它比2%利多卡因肾上腺素透明质酸酶混合物更有效。